Skip to Main Content

Top of the morning to you, and a fine one it is. Crystal clear blue skies and cool breezes are wafting about the Pharmalot campus, where the short person will soon rise for gainful summer employment and the official mascot is bounding about the grounds with a favorite playmate. As for us, we are firing up the coffee kettle to brew still another cup of stimulation. As always, you are invited to join us. Our choice today is pumpkin spice — a tasty head start on autumn, yes? Meanwhile, here is the latest laundry list of interesting items. We hope all goes well and the day is meaningful and productive. And do keep in touch. …

Drugmakers are launching new medicines at record-high prices this year, highlighting their pricing power even as Congress moves to cut the $500 billion-plus annual bill for prescription drugs in the U.S., Reuters reports. At the same time, some pharmaceutical manufacturers are disclosing less information about the pricing of those treatments, which have come under greater scrutiny in recent years. The median annual price of 13 novel drugs approved for chronic conditions by the U.S. Food and Drug Administration so far this year is $257,000. Last year, the median annual price rose to $180,000 for the 30 drugs first marketed through mid-July 2021, according to a study in JAMA.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Create a display name to comment

This name will appear with your comment